William Haseltine will retire as chairman and CEO of Human Genome Sciences, the company said. He intends to step down once a new CEO has been appointed.
Donald Segal has been appointed president and CEO of Aurora, Canada-based Helix BioPharma. He has been executive vice president of Helix since 1995. Segal replaces Jerome McElroy as president. McElroy will remain chairman of the board.